IDI1 Antibodies

Santa Cruz Biotechnology provides a broad selection of IDI1 Antibodies for research focused on understanding isoprenoid biosynthesis. IDI1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IDI1, or Isoprenoid Biosynthesis Enzyme 1, plays a crucial role in the mevalonate pathway, which is essential for the synthesis of cholesterol and other isoprenoids. The mevalonate pathway maintains cellular functions, including membrane integrity, signaling, and the synthesis of important biomolecules. Understanding IDI1 function advances knowledge of metabolic disorders and supports the development of therapeutic strategies. Research into IDI1 continues to reveal new insights about cellular metabolism and potential therapeutic targets. Investigating IDI1's role in isoprenoid biosynthesis helps identify novel treatment approaches for metabolic conditions. Santa Cruz Biotechnology monoclonal antibodies for IDI1 research enable scientists to advance understanding of metabolic pathways and their impact on human health.